187 related articles for article (PubMed ID: 30959136)
1. Assessment of fed-batch cultivation strategies for an inducible CHO cell line.
Mellahi K; Brochu D; Gilbert M; Perrier M; Ansorge S; Durocher Y; Henry O
J Biotechnol; 2019 Jun; 298():45-56. PubMed ID: 30959136
[TBL] [Abstract][Full Text] [Related]
2. Process intensification for the production of rituximab by an inducible CHO cell line.
Mellahi K; Brochu D; Gilbert M; Perrier M; Ansorge S; Durocher Y; Henry O
Bioprocess Biosyst Eng; 2019 May; 42(5):711-725. PubMed ID: 30673843
[TBL] [Abstract][Full Text] [Related]
3. Process development for an inducible rituximab-expressing Chinese hamster ovary cell line.
Mellahi K; Cambay F; Brochu D; Gilbert M; Perrier M; Ansorge S; Durocher Y; Henry O
Biotechnol Prog; 2019 Jan; 35(1):e2742. PubMed ID: 30414355
[TBL] [Abstract][Full Text] [Related]
4. Raman-based dynamic feeding strategies using real-time glucose concentration monitoring system during adalimumab producing CHO cell cultivation.
Domján J; Fricska A; Madarász L; Gyürkés M; Köte Á; Farkas A; Vass P; Fehér C; Horváth B; Könczöl K; Pataki H; Nagy ZK; Marosi GJ; Hirsch E
Biotechnol Prog; 2020 Nov; 36(6):e3052. PubMed ID: 32692473
[TBL] [Abstract][Full Text] [Related]
5. Enhanced cell culture performance using inducible anti-apoptotic genes E1B-19K and Aven in the production of a monoclonal antibody with Chinese hamster ovary cells.
Figueroa B; Ailor E; Osborne D; Hardwick JM; Reff M; Betenbaugh MJ
Biotechnol Bioeng; 2007 Jul; 97(4):877-92. PubMed ID: 17099908
[TBL] [Abstract][Full Text] [Related]
6. Heat shock protein 27 overexpression in CHO cells modulates apoptosis pathways and delays activation of caspases to improve recombinant monoclonal antibody titre in fed-batch bioreactors.
Tan JG; Lee YY; Wang T; Yap MG; Tan TW; Ng SK
Biotechnol J; 2015 May; 10(5):790-800. PubMed ID: 25740626
[TBL] [Abstract][Full Text] [Related]
7. Perfusion seed cultures improve biopharmaceutical fed-batch production capacity and product quality.
Yang WC; Lu J; Kwiatkowski C; Yuan H; Kshirsagar R; Ryll T; Huang YM
Biotechnol Prog; 2014; 30(3):616-25. PubMed ID: 24574326
[TBL] [Abstract][Full Text] [Related]
8. Metabolic engineering of CHO cells to alter lactate metabolism during fed-batch cultures.
Toussaint C; Henry O; Durocher Y
J Biotechnol; 2016 Jan; 217():122-31. PubMed ID: 26603123
[TBL] [Abstract][Full Text] [Related]
9. The effect of hyperosmolality application time on production, quality, and biopotency of monoclonal antibodies produced in CHO cell fed-batch and perfusion cultures.
Qin J; Wu X; Xia Z; Huang Z; Zhang Y; Wang Y; Fu Q; Zheng C
Appl Microbiol Biotechnol; 2019 Feb; 103(3):1217-1229. PubMed ID: 30554388
[TBL] [Abstract][Full Text] [Related]
10. Development of hyper osmotic resistant CHO host cells for enhanced antibody production.
Kamachi Y; Omasa T
J Biosci Bioeng; 2018 Apr; 125(4):470-478. PubMed ID: 29233458
[TBL] [Abstract][Full Text] [Related]
11. Cell-controlled hybrid perfusion fed-batch CHO cell process provides significant productivity improvement over conventional fed-batch cultures.
Hiller GW; Ovalle AM; Gagnon MP; Curran ML; Wang W
Biotechnol Bioeng; 2017 Jul; 114(7):1438-1447. PubMed ID: 28128436
[TBL] [Abstract][Full Text] [Related]
12. A Single Dynamic Metabolic Model Can Describe mAb Producing CHO Cell Batch and Fed-Batch Cultures on Different Culture Media.
Robitaille J; Chen J; Jolicoeur M
PLoS One; 2015; 10(9):e0136815. PubMed ID: 26331955
[TBL] [Abstract][Full Text] [Related]
13. Amino acid and glucose metabolism in fed-batch CHO cell culture affects antibody production and glycosylation.
Fan Y; Jimenez Del Val I; Müller C; Wagtberg Sen J; Rasmussen SK; Kontoravdi C; Weilguny D; Andersen MR
Biotechnol Bioeng; 2015 Mar; 112(3):521-35. PubMed ID: 25220616
[TBL] [Abstract][Full Text] [Related]
14. S-Sulfocysteine simplifies fed-batch processes and increases the CHO specific productivity via anti-oxidant activity.
Hecklau C; Pering S; Seibel R; Schnellbaecher A; Wehsling M; Eichhorn T; Hagen Jv; Zimmer A
J Biotechnol; 2016 Jan; 218():53-63. PubMed ID: 26654938
[TBL] [Abstract][Full Text] [Related]
15. Differential gene expression of a feed-spiked super-producing CHO cell line.
Reinhart D; Damjanovic L; Castan A; Ernst W; Kunert R
J Biotechnol; 2018 Nov; 285():23-37. PubMed ID: 30157452
[TBL] [Abstract][Full Text] [Related]
16. Biphasic addition strategy of hypoxanthine and thymidine for improving monoclonal antibody production.
Chen F; Ye Z; Zhao L; Liu X; Fan L; Tan WS
J Biosci Bioeng; 2012 Sep; 114(3):347-52. PubMed ID: 22652083
[TBL] [Abstract][Full Text] [Related]
17. Perfusion Cell Culture Decreases Process and Product Heterogeneity in a Head-to-Head Comparison With Fed-Batch.
Walther J; Lu J; Hollenbach M; Yu M; Hwang C; McLarty J; Brower K
Biotechnol J; 2019 Feb; 14(2):e1700733. PubMed ID: 29851298
[TBL] [Abstract][Full Text] [Related]
18. Tuning monoclonal antibody galactosylation using Raman spectroscopy-controlled lactic acid feeding.
W Eyster T; Talwar S; Fernandez J; Foster S; Hayes J; Allen R; Reidinger S; Wan B; Ji X; Aon J; Patel P; Ritz DB
Biotechnol Prog; 2021 Jan; 37(1):e3085. PubMed ID: 32975043
[TBL] [Abstract][Full Text] [Related]
19. A robust feeding strategy to maintain set-point glucose in mammalian fed-batch cultures when input parameters have a large error.
Konakovsky V; Clemens C; Müller MM; Bechmann J; Herwig C
Biotechnol Prog; 2017 Mar; 33(2):317-336. PubMed ID: 28127895
[TBL] [Abstract][Full Text] [Related]
20. Towards the development of automated fed-batch cell culture processes at microscale.
Wiegmann V; Giaka M; Martinez CB; Baganz F
Biotechniques; 2019 Nov; 67(5):238-241. PubMed ID: 31529987
[No Abstract] [Full Text] [Related]
[Next] [New Search]
